Showing 2761-2770 of 4063 results for "".
- Nicox Receives Formulation Patent Extending NCX 470 US Patent Coverage to 2039https://modernod.com/news/nicox-receives-formulation-patent-extending-ncx-470-us-patent-coverage-to-2039/2477270/Nicox has received approval from the U.S. Patent and Trademark Office of a formulation patent for NCX 470, extending the U.S. patent coverage to 2039. NCX 470, a novel second gener
- CRST: 2019 Year in Focushttps://modernod.com/news/2019-year-in-focus/2477197/Fueled by an influx of investment capital in recent years and a streamlined regulatory review process, the number of ophthalmic products approved or introduced in 2019 continued to rise steadily throughout the year. According to recent figures from pharmaceutical market research company Strategic
- Market Scope: Ophthalmic Deals Surge in 2018-2019; Most Transactions Involve New Ventureshttps://modernod.com/news/market-scope-ophthalmic-deals-surge-in-2018-2019-most-transactions-involve-new-ventures/2477195/Ophthalmic deals garnered over $9 billion from January 2018 through October 2019, driven largely by dry eye and retina related fundraising. Over 100 transactions occurred during this period, and over 80 percent of transaction are categorized as new ventures. The Novartis acquisition of Xii
- Lineage Provides Update on Patient Enrollment in Phase 1/2a Clinical Study of OpRegen for the Treatment of Dry AMDhttps://modernod.com/news/lineage-provides-update-on-patient-enrollment-in-phase-1-2a-clinical-study-of-opregen-for-the-treatment-of-dry-amd/2477194/Lineage Cell Therapeutics announced additional patient data from its ongoing phase 1/2a clinical study of OpRegen, the company’s retinal pigment epithelium (RPE) transplant therapy, for the treatment of dry age-related macular degeneration (AMD). The first Cohort 4 patient treated using bo
- 5,736 of the World’s Poorest People Received the Gift of Sight in 2019 at the Tej Kohli Cornea Institutehttps://modernod.com/news/5736-of-the-worlds-poorest-people-received-the-gift-of-sight-in-2019-at-the-tej-kohli-cornea-institute/2477189/On the fourth anniversary of the Tej Kohli Cornea Institute in Hyderabad, the Tej Kohli Foundation has renewed its commitment of $14 million of funding from 2020. During 2019, 5,736 individuals were cured of blindness or severe visual impairment at The Tej Kohli Cornea Institute, according to new
- The American Optometric Association Urges Employers to Pledge to Make 2020 the Year of the Eye Examhttps://modernod.com/news/the-american-optometric-association-urges-employers-to-pledge-to-make-2020-the-year-of-the-eye-exam/2477180/As part of the American Optometric Association’s (AOA) #2020EyeExam initiative, the organization and doctors of optometry nationwide are calling upon visionary companies across the country to join the 2020 Employer Pledge program–affirming the importance of caring for the overall health and
- ImprimisRx’s FDA-Registered Outsourcing Facility Issued California Licensehttps://modernod.com/news/imprimisrxs-fda-registered-outsourcing-facility-issued-california-license/2477158/ImprimisRx announced that on December 9, 2019, its FDA-registered 503B outsourcing facility received a non-resident operating license and has now begun shipping into California. This license allows California-based ophthalmologists, optometrists, surgery centers and hospitals to order and stock I
- Mark McGrath to Headline Celebration at Optometry’s Meeting 2020https://modernod.com/news/mark-mcgrath-to-headline-celebration-at-optometrys-meeting-2020/2477126/The American Optometric Association has announced that it is celebrating the decade of the 90s at its annual Optometry’s Meeting, June 24-28, in National Harbor, Maryland/Washington, D.C. “Mark McGrath’s ’90s Experience” will headline the closing Celebration o
- Ophthalmic Laser Market Expected to Total $406 Million in 2019https://modernod.com/news/ophthalmic-laser-market-expected-to-total-406-million-in-2019/2477117/Global revenue for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total nearly $406 million in 2019 and grow at a compound annual rate of 1.6 percent from 2019 to 2024, according to Market Scope estimates. Factor
- CovalentCareers Releases 2019 Optometrist Reporthttps://modernod.com/news/covalentcareers-releases-2019-optometrist-report/2477100/Career development company CovalentCareers has released its 2019 Optometrist Report, which is now available for free for eyecare professionals. Based on data collected from 1,181 optometrists, optometry studen